Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127645391 | 12764539 | 1 | I | 2013 | 20160728 | 20160920 | 20160920 | PER | US-ASTRAZENECA-2016SE82661 | ASTRAZENECA | 77.00 | YR | F | Y | 81.20000 | KG | 20160920 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127645391 | 12764539 | 1 | PS | PULMICORT TURBUHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 2 PUFFS TWICE A DAY | 20929 | INHALATION POWDER | |||||||||
| 127645391 | 12764539 | 2 | SS | METOPROLOL SUCCINATE ER | METOPROLOL SUCCINATE | 1 | Oral | U | U | 0 | 100 | MG | MODIFIED-RELEASE TABLET | BID | |||||
| 127645391 | 12764539 | 3 | SS | METOPROLOL SUCCINATE ER | METOPROLOL SUCCINATE | 1 | Oral | U | U | 0 | 100 | MG | MODIFIED-RELEASE TABLET | BID | |||||
| 127645391 | 12764539 | 4 | SS | METOPROLOL SUCCINATE ER | METOPROLOL SUCCINATE | 1 | Oral | U | U | 0 | 50 | MG | MODIFIED-RELEASE TABLET | BID | |||||
| 127645391 | 12764539 | 5 | SS | METOPROLOL SUCCINATE ER | METOPROLOL SUCCINATE | 1 | Oral | U | U | 0 | 50 | MG | MODIFIED-RELEASE TABLET | BID | |||||
| 127645391 | 12764539 | 6 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 2 PUFFS, TWO TIMES A DAY | 0 | ||||||||||
| 127645391 | 12764539 | 7 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 127645391 | 12764539 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 127645391 | 12764539 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127645391 | 12764539 | 10 | C | PROBIOTIC ACIDOPHILUS | LACTOBACILLUS ACIDOPHILUS | 1 | Oral | DAILY | 0 | ||||||||||
| 127645391 | 12764539 | 11 | C | OMEGA XL | DIETARY SUPPLEMENT | 1 | 0 | 2 | DF | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127645391 | 12764539 | 1 | Dyspnoea |
| 127645391 | 12764539 | 2 | Hypertension |
| 127645391 | 12764539 | 3 | Heart rate abnormal |
| 127645391 | 12764539 | 4 | Hypertension |
| 127645391 | 12764539 | 5 | Heart rate abnormal |
| 127645391 | 12764539 | 6 | Asthma |
| 127645391 | 12764539 | 7 | Hypertension |
| 127645391 | 12764539 | 8 | Hypertension |
| 127645391 | 12764539 | 9 | Blood cholesterol abnormal |
| 127645391 | 12764539 | 10 | Gastric disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127645391 | 12764539 | Dyspnoea | |
| 127645391 | 12764539 | Off label use | |
| 127645391 | 12764539 | Pain in extremity | |
| 127645391 | 12764539 | Spondylitis | |
| 127645391 | 12764539 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127645391 | 12764539 | 1 | 2013 | 0 | ||
| 127645391 | 12764539 | 6 | 2014 | 0 | ||
| 127645391 | 12764539 | 7 | 2015 | 0 | ||
| 127645391 | 12764539 | 8 | 2015 | 0 | ||
| 127645391 | 12764539 | 9 | 2014 | 0 |